These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23455602)

  • 1. What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).
    Kovshoff H; Vrijens M; Thompson M; Yardley L; Hodgkins P; Sonuga-Barke EJ; Danckaerts M
    Eur Child Adolesc Psychiatry; 2013 Sep; 22(9):533-42. PubMed ID: 23455602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research.
    Ibrahim K; Donyai P
    Atten Defic Hyperact Disord; 2018 Dec; 10(4):273-283. PubMed ID: 29982921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices.
    Sheldrick RC; Leslie LK; Rodday AM; Parsons SK; Saunders TS; Wong JB
    J Atten Disord; 2015 Jul; 19(7):569-77. PubMed ID: 23142852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
    Chung J; Tchaconas A; Meryash D; Adesman A
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):335-43. PubMed ID: 27105063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
    Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
    BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
    Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
    J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
    Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatricians' decision making about prescribing stimulant medications for children with attention-deficit/hyperactivity disorder.
    Chow SJ; Sciberras E; Gillam LH; Green J; Efron D
    Child Care Health Dev; 2014 May; 40(3):301-8. PubMed ID: 23445484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD Medication Trends in Turkey: 2009-2013.
    Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
    J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.